Skip to content

CorMedix CRMD Interest coverage

Interest coverage at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
7.1×+1.7×
ITG
Integer HoldingsITGR
5.3×+1.5×
IAR
Integra LifeSciencesIART
-5.4×-5.6×
Emergent Biosolutions logo
Emergent BiosolutionsEBS
+1.3×
Abbott logo
AbbottABT
14.4×+1.4×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-55.3×-61.9×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on trailing twelve months.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's interest coverage?
CorMedix (CRMD) reported interest coverage of 54× in Q4 2025.
What is the long-term trend for CorMedix's interest coverage?
Over 4 years (2020 to 2025), CorMedix's interest coverage has grown at a -49.3% compound annual growth rate (CAGR), from -819.3× to 54×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.